By Alec Mattinson2015-02-04T23:59:00
GlaxoSmithKline’s (GSK) consumer healthcare revenues dipped by 1% last year as the global pharma giant struggled to overcome supply chain problems in the US and Europe.
Already have an account? Sign in here
Already have an account? Sign in here
You’ve used up your article allowance